Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells

Fig. 3

Flow cytometry analysis of P4 and P6 peptides binding to off-target cells. P4- and P6-FITC conjugates were incubated at the indicated concentrations with cells to ascertain the dose-binding response. The data was collected from Becton Dickson FACS Calibur cell analyzer and analyzed with Flow Jo software. Aside from the strong dose–response to A20 target cells P4 binds a small population of NB4 and HL-60 myeloid leukemic cells but not to PBMC or MOPC cells

Back to article page